AMAG Pharmaceuticals (AMAG)

Add to Watchlists
Create an Alert
66.35 +0.17  +0.26% NASDAQ May 22, 8:00PM Delayed 2m USD
View Full Chart
AMAG Price Chart
View All Events

AMAG Events

Date Type Description
05/05/2015 08:00 EDT Misc AMAG Pharmaceuticals Inc First Quarter Earnings Conference Call in 2015
05/05/2015 Earnings AMAG Pharmaceuticals Inc First Quarter Earnings in 2015 Release
02/09/2015 16:30 EST Misc AMAG Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
02/09/2015 Earnings AMAG Pharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
01/14/2015 08:00 PST Misc AMAG Pharmaceuticals, Inc. At JPMorgan Healthcare Conference
01/11/2015 Misc AMAG Pharmaceuticals Provides Business Update and 2015 Financial Guidance
11/20/2014 09:20 GMT Misc AMAG Pharmaceuticals Announces Presentation at Jefferies 2014 Global Healthcare Conference in London
11/12/2014 Misc AMAG Pharmaceuticals Acquires Lumara Health's Maternal Health Business
10/30/2014 08:00 EDT Misc Q3 2014 AMAG Pharmaceuticals, Inc. Earnings Conference Call
10/30/2014 Earnings Q3 2014 AMAG Pharmaceuticals, Inc. Earnings Results
View All Performance Charts

AMAG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AMAG Pharmaceuticals is up 272.5% over the last year vs S&P 500 Total Return up 14.64%, Endocyte down 3.88%, and Seattle Genetics up 29.35%.

PDF Report for AMAG

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AMAG Pro Report PDF
Advertisement

AMAG Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.amagpharma.com
  • IR Website: http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

AMAG Pharmaceuticals Inc is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The Company markets Makena; Feraheme, Injection for Intravenous ("IV") use; and MuGard, Mucoadhesive Oral Wound Rinse.

AMAG Excel Add-In Codes

  • Name: =YCI("AMAG","name")
  • Description: =YCI("AMAG","description")
  • Sector: =YCI("AMAG","sector")
  • Industry: =YCI("AMAG","industry")
  • Est. Current Fiscal Year End: =YCI("AMAG","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.